Drug Shortage Report for MYLAN-CIMETIDINE

Last updated on 2017-09-08 History
Report ID 9108
Drug Identification Number 02227460
Brand name MYLAN-CIMETIDINE
Common or Proper name CIMETIDINE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) CIMETIDINE
Strength(s) 600MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500BT
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-05-01
Estimated end date
Actual end date 2017-09-07
Shortage status Resolved
Updated date 2017-09-08
Company comments Discontinuation reported under ID 16096.
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2017-09-08 French Compare
v6 2017-09-08 English Compare
v5 2017-09-08 English Compare
v4 2017-07-21 French Compare
v3 2017-07-21 English Compare
v2 2017-05-05 French Compare
v1 2017-05-05 English Compare

Showing 1 to 7 of 7